Fundraising FoxAerpio Therapeutics
Cincinnati, US · Founded 2011 · Delaware corporation · 4 known investors
Find your way into Aerpio Therapeutics
Sign up to see every warm intro you have to Aerpio Therapeutics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Aerpio Therapeutics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
Aerpio Therapeutics was founded in 2011 by Robert Shalwitz and Joseph Gardner.
Board
Investors · 4
How we know: CincyTech's portfolio page · Not right? Tell us
How we know: Sofinnova Ventures's portfolio page · Not right? Tell us
How we know: press coverage · Not right? Tell us
How we know: board seat on SEC Form D · funding news · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$35M disclosed across 4 rounds · 2011–2016
▶$3.5MraisedNov 2016 · 53 investors · BiotechnologyRule 506(b)
- Joseph H. GardnerExecutive Officer, Director
- John RiceDirector
- Paul WeissDirector
- Campbell MurrayDirector
- Duane NashDirector
- Steve PakolaExecutive Officer
- Reinhard AmbrosDirector
- Anupam DalalDirector
- Chau KhuongDirector
- Adrienne GravesDirector
- Kevin PetersExecutive Officer
- Muneer SatterDirector
- Offering amount
- $4.6M
- Amount sold
- $3.5M
- First sale
- Oct 2016
- Incorporated
- Corporation, Delaware, 2011
- Federal exemptions
- 06b
▶$4.5MraisedApr 2016 · 54 investors · BiotechnologyRule 506(b)
- Reinhard AmbrosDirector
- Duane NashDirector
- Paul WeissDirector
- Muneer SatterDirector
- Adrienne GravesDirector
- Joseph H. GardnerExecutive Officer
- Kevin PetersExecutive Officer
- Chau KhuongDirector
- Steve PakolaExecutive Officer
- Anupam DalalDirector
- John RiceDirector
- Campbell MurrayDirector
- Offering amount
- $9.2M
- Amount sold
- $4.5M
- First sale
- Mar 2016
- Incorporated
- Corporation, Delaware, 2011
- Federal exemptions
- 06b
▶$22MraisedMay 2014 · 37 investors · BiotechnologyRule 506(b)
- Campbell MurrayDirector
- Kevin PetersExecutive Officer
- Joseph H. GardnerExecutive Officer, Director
- Paul WeissDirector
- Anupam DalalDirector
- Lauren SilvermanDirector
- Muneer SatterDirector
- Chau KhuongDirector
- Robert ShalwitzExecutive Officer
- Adrienne GravesDirector
- John RiceDirector
- Duane NashDirector
- Offering amount
- $22M
- Amount sold
- $22M
- First sale
- Apr 2014
- Incorporated
- Corporation, Delaware, 2011
- Federal exemptions
- 06b
▶$5MraisedJan 2012 · 24 investors · BiotechnologyRule 506(b)
- Robert ShalwitzExecutive Officer
- John RiceDirector
- Kevin PetersExecutive Officer
- Anupam DalalDirector
- Paul WeissDirector
- Ian A.W. HowesExecutive Officer
- Campbell MurrayDirector
- Joseph H. GardnerExecutive Officer, Director
- Offering amount
- $5M
- Amount sold
- $5M
- First sale
- Dec 2011
- Incorporated
- Corporation, Delaware, 2011
- Federal exemptions
- 06
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Founder mafia
2 people who came through Aerpio Therapeutics went on to found or lead other companies.
Non-dilutive funding · 2 SBIR/STTR awards
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2019 | $207.3K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2015 | $225K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
Frequently asked questions
- Who founded Aerpio Therapeutics?
- Aerpio Therapeutics was founded by Robert Shalwitz, Joseph Gardner in 2011.
- Who are Aerpio Therapeutics's investors?
- Aerpio Therapeutics's investors include CincyTech, Sofinnova Ventures, Ally Bridge Group, OrbiMed.
- How much funding has Aerpio Therapeutics raised?
- Aerpio Therapeutics has disclosed $35M raised across 4 rounds.
- Where is Aerpio Therapeutics headquartered?
- Aerpio Therapeutics is headquartered in Cincinnati, US.